How the pandemic helped secure a rare cancer drug for Menarini

The leadership at Stemline had been in negotiations with one company for over a year, when they got a surprise note out of Italy: Menarini, the century-old, Florentine pharma company wanted to know if they’d be interested in a partnership on their new drug.